Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Watson

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|March 31, 2001
Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23Y H Tseng, D Vicent, J Zhu, et al.
Cancer Research|April 16, 1998
Expression of lumican in human breast carcinomaE Leygue, L Snell, H Dotzlaw, et al.
British Journal of Cancer|November 22, 2012
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancerN R West, S E Kost, S D Martin, et al.
The Journal of Pathology|October 31, 2000
Lumican and decorin are differentially expressed in human breast carcinomaE Leygue, L Snell, H Dotzlaw, et al.
Cancer Research|December 5, 2000
Altered expression of estrogen receptor coregulators during human breast tumorigenesisL C Murphy, S L Simon, A Parkes, et al.
Cancer Research|June 13, 2000
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markersS L Simon, A Parkes, E Leygue, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosisA B Hodsman, L J Fraher, P H Watson, et al.
Histopathology|February 14, 2008
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersG P Skliris, F Hubé, I Gheorghiu, et al.
British Journal of Cancer|November 27, 1999
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasisJ W Clark, L Snell, R P Shiu, et al.
Biology of Reproduction|April 1, 1994
A growth factor phenotype map for ovine preimplantation developmentA J Watson, P H Watson, M Arcellana-Panlilio, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|March 31, 2001
Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23Y H Tseng, D Vicent, J Zhu, et al.
Cancer Research|April 16, 1998
Expression of lumican in human breast carcinomaE Leygue, L Snell, H Dotzlaw, et al.
British Journal of Cancer|November 22, 2012
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancerN R West, S E Kost, S D Martin, et al.
The Journal of Pathology|October 31, 2000
Lumican and decorin are differentially expressed in human breast carcinomaE Leygue, L Snell, H Dotzlaw, et al.
Cancer Research|December 5, 2000
Altered expression of estrogen receptor coregulators during human breast tumorigenesisL C Murphy, S L Simon, A Parkes, et al.
Cancer Research|June 13, 2000
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markersS L Simon, A Parkes, E Leygue, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosisA B Hodsman, L J Fraher, P H Watson, et al.
Histopathology|February 14, 2008
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersG P Skliris, F Hubé, I Gheorghiu, et al.
British Journal of Cancer|November 27, 1999
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasisJ W Clark, L Snell, R P Shiu, et al.
Biology of Reproduction|April 1, 1994
A growth factor phenotype map for ovine preimplantation developmentA J Watson, P H Watson, M Arcellana-Panlilio, et al.
Pageof 10